Yesterday during its annual news conference, the National Foundation for Infectious Diseases (NFID) said less than 1 in 5 ...

Respiratory Syncytial Virus RSV is a common respiratory virus primarily affecting young children Here are some remedies to ...

Most people notice this when air pressure changes rapidly, such as when a plane ascends or descends. This happens because the ...

Enanta Pharmaceuticals' EDP-323 shows promising Phase 2a trial results, significantly reducing RSV viral load and symptoms ...

Older people should take a new vaccine to protect them against Respiratory Syncytial Virus (RSV), according to new research ...

Leaders from the Pennsylvania Departments of Health and Insurance this week encouraged all Pennsylvanians to stay up to date on their annual vaccinations to protect against flu, COVID-19, and ...

With respiratory viruses ramping up as we look to cooler days, vaccination season has arrived again. The newest vaccine to protect against Covid-19 has hit pharmacies, and Allegheny County residents ...

Forecasts suggest respiratory infections will be similar to last year's season. Vaccination rates will be a factor in the ...

Monthly increases in SUID in 2021 coincided with a resurgence of seasonal respiratory viruses, particularly respiratory syncytial virus (RSV), suggesting that the shift in SUID rates may be associated ...

Fall brings cooler days and more time indoors. This makes it easier for viruses like influenza, COVID-19 and respiratory ...

Enanta Pharmaceuticals Announces Positive Topline Results for EDP-323 in a Phase 2a Human Challenge Study of Healthy Adults Infected With RSV ...

Respiratory syncytial virus (RSV) is a leading cause of severe illness in infants, with no effective treatment. Results of a phase 2 trial suggested that ziresovir may have efficacy in the ...